Clinical Trial Update: Effects of Ketamine and Risperidone on Cognition [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the cognitive effects of ketamine and risperidone in healthy volunteers and individuals with schizophrenia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ketamine (ketamine)
• Risperdal (risperidone)

Snippet

Sponsor: University of Manchester | Conditions: Healthy Volunteers, Schizophrenia | Phase 4 | Status: COMPLETED